九典制药(300705.SZ)：马来酸曲美布汀片获得药品注册证书

Core Viewpoint - Jiutian Pharmaceutical (300705.SZ) has received the Drug Registration Certificate from the National Medical Products Administration for its drug, Trimebutine Maleate Tablets, which is indicated for the treatment of symptoms related to irritable bowel syndrome and gastrointestinal motility disorders [1] Group 1 - The drug Trimebutine Maleate Tablets is used to improve symptoms such as loss of appetite, nausea, vomiting, belching, abdominal distension, borborygmi, abdominal pain, diarrhea, and constipation [1] - Trimebutine Maleate was first approved for marketing in France in 1970 and is currently available in various forms including tablets, capsules, and dry mixed suspensions in both domestic and international markets [1]